Skip to main content

Table 2 The AFP model as a predictor of response, recurrence, and survival in patients undergoing TACE

From: Risk stratification of patients with hepatocellular carcinoma undergoing trans arterial chemoembolization using an alpha-fetoprotein model

TACE

Low-risk

High-risk

P value

Sig.

n = 57

n = 75

Response

Complete response

52 (91.2%)

55 (73.3%)

0.057

NS

Partial response

5 (8.8%)

16 (21.3%)

Stationary disease

0 (0.0%)

2 (2.7%)

Progressive disease

0 (0.0%)

2 (2.7%)

Recurrence

No recurrence

15 (28.8%)

12 (21.8%)

0.403

NS

Recurrence

37 (71.2%)

43 (78.2%)

Range

10–42

3–32

Survival

Negative

37 (64.9%)

59 (78.7%)

0.079

NS

Positive

20 (35.1%)

16 (21.3%)

  1. NS Nonsignificant